FDA Sets Agenda To Kickstart MDUFA Talks
Executive Summary
Regulators, industry, patient advocates and other stakeholders will meet at the US agency's headquarters on 7 April to discuss priorities for the next round of medical device user-fee negotiations.
You may also be interested in...
FDA May Webcast First MDUFA Meeting, Postpone Or Cancel Others
The FDA says it is looking to webcast the upcoming 7 April MDUFA user fee public meeting, which is slated to be one of the most important agency meetings of the year. The decision comes in light of difficulties holding in-person meetings as the US grapples with the ongoing coronavirus crisis.
CDRH’s Shuren Talks MDUFA, Industry’s Premarket Wants, Emerging Technologies, And More In Wide-Ranging Interview
In an exclusive interview with Medtech Insight, FDA device center director Jeff Shuren said the agency will possibly discuss issues such as postmarket surveillance and patient engagement in upcoming MDUFA negotiations. He also talked about some recent big wins for the agency and his vision for the coming year.
CDRH’s Shuren Talks MDUFA, Industry’s Premarket Wants, Emerging Technologies, And More In Wide-Ranging Interview
In an exclusive interview with Medtech Insight, FDA device center director Jeff Shuren said the agency will possibly discuss issues such as postmarket surveillance and patient engagement in upcoming MDUFA negotiations. He also talked about some recent big wins for the agency and his vision for the coming year.